BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 308101)

  • 1. Distribution of T-lymphocytes and B-lymphocytes in peripheral blood and effusions of patients with cancer.
    Domagala W; Emeson EE; Koss LG
    J Natl Cancer Inst; 1978 Aug; 61(2):295-300. PubMed ID: 308101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of lymphocytes in effusions of patients with tuberculosis or malignant disease.
    Falcão RP; Bottura C
    Clin Exp Immunol; 1981 Jul; 45(1):201-4. PubMed ID: 6975680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T and B lymphocyte enumeration in the diagnosis of lymphocyte-rich pleural fluids.
    Domagała W; Emeson EE; Koss LG
    Acta Cytol; 1981; 25(2):108-10. PubMed ID: 6972683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leucocyte migration inhibition and rosette tests in pleural effusion.
    Jakubusek-Przylipiak M; Janicka G; Zagorecka A; Pregowski W
    Eur J Respir Dis; 1980 Apr; 61(2):67-70. PubMed ID: 6969182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid alpha-naphthyl acetate esterase staining of lymphocytes in pleural effusions.
    Petersson T
    Acta Cytol; 1982; 26(2):109-14. PubMed ID: 6177149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
    Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Elevated soluble interleukin-2 receptor and interleukin-2 receptor positive cells in carcinomatous pleural effusions].
    Kojiro N; Moriwaki Y; Ito M; Nishiki M; Shirasaka T; Kokubu T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jan; 28(1):100-4. PubMed ID: 2355670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between cell composition of pleural effusions in patients with pulmonary carcinomas and their clinical courses.
    Yamagishi K; Tajima M; Suzuki A; Kimura K
    Acta Cytol; 1976; 20(6):537-41. PubMed ID: 1069449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lymphocyte rosettes as helping factor in the cytodiagnosis of body cavity effusions].
    Hoppe E
    Radiobiol Radiother (Berl); 1982 Mar; 23(2):134-48. PubMed ID: 7100420
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lymphocytosis in malignant effusions].
    Hruczkowska E
    Pol Tyg Lek; 1969 Dec; 24(49):1895-6. PubMed ID: 5369043
    [No Abstract]   [Full Text] [Related]  

  • 11. Flow cytometric quantitation of natural killer cells and T lymphocytes expressing T-cell receptors alpha/beta and gamma/delta is not helpful in distinguishing benign from malignant body cavity effusions.
    Cornfield DB; Gheith SM
    Cytometry B Clin Cytom; 2009 May; 76(3):213-7. PubMed ID: 18803280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte subpopulations in peripheral blood and malignant effusions of cancer patients.
    Robinson E; Segal R; Vesely Z; Mekori T
    Eur J Cancer Clin Oncol; 1986 Feb; 22(2):191-3. PubMed ID: 2938959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
    Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
    Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
    Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparison of different rosette assay systems for the determination of T-lymphocytes in patients with solid malignant tumors.
    Gramatzki M; Kalden JR
    Z Immunitatsforsch Immunobiol; 1978 Dec; 155(2):104-17. PubMed ID: 311555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic behaviour of the cellular populations in the pleural or peritoneal effusions from patients with malignant diseases.
    Mihăilescu E; Micu D; Cheţa N; Chiriloiu C; Georgescu M; Vilău C
    Med Interne; 1986; 24(3):227-33. PubMed ID: 2430328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in pleural fluid characteristics, white cell count and biochemistry of tuberculous and malignant pleural effusions.
    Liam CK; Lim KH; Wong CM
    Med J Malaysia; 2000 Mar; 55(1):21-8. PubMed ID: 11072486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymphocyte chemotactic factor in tuberculous pleural effusion].
    Naito T; Ohtsuka M; Ishikawa H; Satoh H; Hasegawa S
    Kekkaku; 1998 Apr; 73(4):307-14. PubMed ID: 9613051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cancer antigen 125 in patients with pleural effusions.
    How SH; Liam CK; Jamalludin AR; Chin SP; Zal AB
    Med J Malaysia; 2006 Dec; 61(5):558-63. PubMed ID: 17623956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte subsets in peripheral blood and pleural fluid.
    Lucivero G; Pierucci G; Bonomo L
    Eur Respir J; 1988 Apr; 1(4):337-40. PubMed ID: 3260873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.